1-3 of 3
Ethel Cesarman
Close
Sort by
Journal Articles

Simplified detection of Epstein-Barr virus for diagnosis of endemic Burkitt lymphoma

Andrea Gardner, Julio Alvarez, Caitlyn Genovese, Ryan Snodgrass, Varun Kopparthy, David Erickson, Ethel Cesarman
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3650–3654.
https://doi.org/10.1182/bloodadvances.2022007297
Published: 2022
Includes: Supplemental data
Journal Articles

Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes

Hanna Scholze, Regan E. Stephenson, Raymond Reynolds, Shivem Shah, Rishi Puri, Scott D. Butler, Vicenta Trujillo-Alonso, Matthew R. Teater, Herman van Besien, Destini Gibbs-Curtis, Hideki Ueno, Salma Parvin, Anthony Letai, Susan Mathew, Ankur Singh, Ethel Cesarman, Ari Melnick, Lisa Giulino-Roth
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5226–5231.
https://doi.org/10.1182/bloodadvances.2020002580
Published: 2020
Includes: Multimedia, Supplemental data
Journal Articles

Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas

Clinical Trials & Observations
Erin G. Reid, David Looney, Frank Maldarelli, Ariela Noy, David Henry, David Aboulafia, Juan Carlos Ramos, Joseph Sparano, Richard F. Ambinder, Jeannette Lee, Ethel Cesarman, Sara Yahyaei, Ronald Mitsuyasu, William Wachsman
Journal: Blood Advances
Blood Adv (2018) 2 (24): 3618–3626.
https://doi.org/10.1182/bloodadvances.2018022095
Published: 2018
Includes: Supplemental data